Linzagolix (Yselty) with hormonal add-back therapy will offer a new at-home treatment option for some women in England with ...

[Gardy Chacha, Standard] Fibroids are non-cancerous growths in the uterus that can cause pain ... Previously, a woman’s treatment options in Kenya were: drugs to ease the pain or to reduce ...

A drug that was approved last year for uterine fibroids is now available for patients of reproductive age who have previously had medical or surgical treatment for endometriosis. In final draft ...

A woman in her 40s presented with complaints of watery discharge (sloughing). These symptoms developed three months after treatment of her Fédération Internationale de Gynécologie et d'Obstétrique ...

Modern medical treatment options for endometriosis were among the main topics at the SEUD Congress (Society of Endometriosis and Uterine Disorders) held in Prague between 24-26 April, where a highly s ...

Newseria nie ponosi odpowiedzialności za treści oraz inne materiały (np. infografiki, zdjęcia) przekazywane w „Biurze ...

A daily oral therapy for uterine fibroids has been recommended for NHS by NICE, providing a new option for around 30,000 women in England and Wales. Theramex's GnRH antagonist Yselty (linzagolix ...

Swiss biopharma company ObsEva has filed its oral GnRH antagonist linzagolix for the treatment of uterine fibroids in the US, hoping to expand the number of women eligible for this type of therapy.

[28] Medical treatments used to manage bleeding symptoms ... This article shows relevant results of the study for the indication uterine fibroids. According to our knowledge it is the largest ...

A NEW daily pill to treat ‘debilitating and life-limiting’ endometriosis will be rolled on the NHS after getting the green ...

A new daily tablet for endometriosis, called linzagolix (also known as Yselty), has been approved for use on the NHS and is ...